#148: Dispensary by IYHP (12/01)

1. Kotak Strategic Situations India Fund II, managed by Kotak Alternate Asset Managers Limited, has invested Rs 940 Crore in Neuberg Diagnostics Private Limited to support Neuberg’s inorganic expansion strategy.

2. Botanic Healthcare raises Rs 250 Cr to drive global expansion.

3. Tata Capital Healthcare Fund II Invests $20M in Harsoria Healthcare.

4. Consist.AI, a Noida-based GenAI-driven healthcare insurance fraud and risk management company, raised Rs 5 Cr in Seed funding.

1. Stryker inks $4.9B deal for blood clot buster Inari Medical

2. Innovaccer raised $275M in Series F funding to expand its healthcare data platform.

3. Aviceda Therapeutics raised $207.5M in an upsized Series C round for immunology treatments.

4. Tenvie Therapeutics raised $200M for its advanced therapeutic platform.

5. Timberlyne Therapeutics raised $180M in Series A funding to accelerate drug development.

6. Evergreen Nephrology raised $130M to enhance kidney care solutions.

7. Fire1 secured $120M to expand its remote monitoring technologies.

8. Ouro Medicines raised $120M in Series A funding for rare disease treatments.

9. Aspect Biosystems raised $115M in Series B funding for its bioprinting platform.

10. Geneoscopy closed $105M in Series C funding for diagnostic advancements.

1. Orbis Medicines raised €90M in Series A funding for oncology innovations.

2. Francis Medical closed $80M in Series C equity financing for minimally invasive therapies.

3. A2 Biotherapeutics raised $80M in Series C funding to develop T-cell therapies.

4. XyloCor Therapeutics raised $67.5M in Series B funding for cardiovascular therapies.

5. Leyden Labs raised $70M for infectious disease prevention.

1. Coave Therapeutics raised €32M in Series A funding for genetic therapy.

2. Deciphex raised €31M in Series C funding to scale its pathology software.

3. Zeto raised $31M in Series B funding for its EEG solutions.

4. Qualified Health raised $30M in seed funding for healthcare technology.

5. Light Horse Therapeutics raised $62M in Series A financing for oncology therapies.

6. Onkos Surgical received a $35M venture loan facility to advance its surgical oncology solutions.

1. Senseera raised $7.1M in seed funding for diagnostic devices.

2. Prudentia Sciences raised $7M for its healthcare solutions.

3. Oxford Cancer Analytics raised $11M in Series A funding.

4. Vitvio raised $2M in pre-seed funding for AI in health.

1. Pison received an investment from Samsung Ventures to scale its technology

Share

• Apollo, Microsoft partner to advance healthcare through AI and digital innovation

• India's SSI Mantra Enables World's First Robotic Cardiac Telesurgeries Performed Over 286 km

• Lilly doubles down on its presence in India with new capability center, plans to hire 1,000+

• India’s Genomic Data Set Unlocks Global Healthcare Breakthroughs

• Zerodha’s Rainmatter, IISc Launch Entrepreneur Program for Deep Tech In Healthcare

• Andreessen Horowitz Partners with Lilly to Launch First-of-Its-Kind Biotech Ecosystem Fund

• China's WuXi Biologics to sell Irish vaccine facility to Merck as US curbs loom

• Diabetes and Heart Disease Rise Alongside Sugary Drink Consumption

• FDA offers new draft guidance to developers of AI-enabled medical devices

• Big Pharma Rushes to China for Deal Prospecting Despite Regulatory Uncertainty

• Merck's HPV vaccine gets China approval for men amid declining sales

That’s It from us, until next week.

Rahul and Aditya